Financial Gravity Asset Management, Inc. Pacira Bio Sciences, Inc. Transaction History

Financial Gravity Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$28.4 - $50.7 $5,793 - $10,342	-204 Closed	0 $0
Q4 2019 Feb 28, 2020	BUY	$36.31 - $46.83 $36 - $46	1 Added 0.49%	204 $54,000
Q2 2019 Jul 26, 2019	BUY	$36.57 - $47.97 $109 - $143	3 Added 1.5%	203 $9,000
Q3 2018 Oct 31, 2018	BUY	$32.85 - $52.0 $6,570 - $10,400	200 New	200 $10,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $851M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.